At the same time, hematopoietic stem cell transplantation (HSCT) is the preferred definitive therapy for DOCK8 deficiency, which, when initiated early, reduces the high morbidity and mortality associated with it (9). This evidence concerns the gene DOCK8 and hyperinsulinemic hypoglycemia, familial, 4.